Pointe Capital Management LLC Merck & Co., Inc. Transaction History

Pointe Capital Management LLC

$171 Million
Q4 2024

A detailed history of Pointe Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pointe Capital Management LLC holds 2,731 shares of MRK stock, worth $240,464. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,731

Previous 2,731 -0.0%

Holding current value

$240,464

Previous $271,000 -0.0%

% of portfolio

0.16%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$96.31 - $114.76 $229,795 - $273,817	-2,386 Reduced 46.63%	2,731 $271,000
Q3 2024 Oct 24, 2024	BUY	$111.15 - $128.97 $24,675 - $28,631	222 Added 4.54%	5,117 $581,000
Q2 2024 Jul 12, 2024	BUY	$123.8 - $132.96 $5,942 - $6,382	48 Added 0.99%	4,895 $606,000
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $3,406 - $3,706	34 Added 0.71%	4,847 $528,000
Q3 2023 Nov 07, 2023	BUY	$102.95 - $114.33 $1,750 - $1,943	17 Added 0.35%	4,813 $495,000
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $28,564 - $31,133	263 Added 5.8%	4,796 $553,000
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $8,029 - $8,959	-78 Reduced 1.69%	4,533 $482,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $215,627 - $276,463	-2,466 Reduced 34.85%	4,611 $512,000
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $6,677 - $7,501	79 Added 1.13%	7,077 $609,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $21,685 - $24,308	295 Added 4.4%	6,998 $574,000
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $4,481 - $5,613	-62 Reduced 0.92%	6,703 $514,000
Q3 2021 Oct 29, 2021	BUY	$71.68 - $78.83 $127,877 - $140,632	1,784 Added 35.82%	6,765 $508,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $9,773 - $10,810	139 Added 2.87%	4,981 $387,000
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $3,580 - $4,217	52 Added 1.09%	4,842 $373,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $11,411 - $12,664	-159 Reduced 3.21%	4,790 $392,000
Q3 2020 Nov 05, 2020	BUY	$73.18 - $82.95 $6,439 - $7,299	88 Added 1.81%	4,949 $411,000
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $23,569 - $32,669	-372 Reduced 7.11%	4,861 $374,000
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $1,008 - $1,138	-13 Reduced 0.25%	5,233 $476,000
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $532 - $580	-7 Reduced 0.13%	5,246 $442,000
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $209 - $244	-3 Reduced 0.06%	5,253 $440,000
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $73,476 - $83,804	1,056 Added 25.14%	5,256 $437,000
Q4 2018 Feb 06, 2019	SELL	$65.24 - $75.71 $2,413 - $2,801	-37 Reduced 0.87%	4,200 $321,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $12,864 - $15,128	223 Added 5.56%	4,237 $301,000
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $1,474 - $1,731	29 Added 0.73%	4,014 $244,000
Q1 2018 May 10, 2018	BUY	$50.96 - $59.23 $1,834 - $2,132	36 Added 0.91%	3,985 $217,000
Q4 2017 Jan 12, 2018	SELL	$51.62 - $61.64 $4,955 - $5,917	-96 Reduced 2.37%	3,949 $222,000
Q3 2017 Oct 16, 2017	BUY	$58.67 - $63.13 $237,320 - $255,360	4,045	4,045 $259,000

Others Institutions Holding MRK

# of Institutions

3,855

Shares Held

1.89B

Call Options Held

15.5M

Put Options Held

13.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $223B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pointe Capital Management LLC with notifications on news.

Account

Pointe Capital Management LLC Merck & Co., Inc. Transaction History